The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts by unknown
RESEARCH Open Access
The impact of crystalloidal and colloidal infusion
preparations on coronary vascular integrity,
interstitial oedema and cardiac performance in
isolated hearts
York A Zausig1†, Daniel Chappell2†, Bernhard F Becker3, Daniel Potschka1, Hendrik Busse1, Kathrin Nixdorf2,
Diane Bitzinger1, Barbara Jacob2 and Matthias Jacob2*
Abstract
Introduction: Recent data suggested an interaction between plasma constituents and the endothelial glycocalyx
to be relevant for vascular barrier function. This might be negatively influenced by infusion solutions, depending
on ionic composition, pH and binding properties. The present study evaluated such an influence of current artificial
preparations.
Methods: Isolated guinea pig hearts were prepared in a modified Langendorff mode and perfused with Krebs-
Henseleit buffer augmented with 1g% human albumin. After equilibration the perfusion was switched to
replacement of one half buffer by either isotonic saline (NaCl), ringer’s acetate (Ri-Ac), 6% and 10% hydroxyethyl
starch (6% and 10% HES, resp.), or 4% gelatine (Gel), the artificial colloids having been prepared in balanced
solution. We analysed glycocalyx shedding, functional integrity of the vascular barrier and heart performance.
Results: While glycocalyx shedding was not observed, diluting albumin concentration towards 0.5g% by artificial
solutions was associated with a marked functional breakdown of vascular barrier competence. This effect was
biggest with isotonic saline and significantly attenuated with artificial colloids, the difference in the pressure
dependent transvascular fluid filtration (basal vs. during infusion in groups NaCl, Ri-Ac, 6% HES, 10% HES and Gel, n
= 6 each) being 0.31 ± 0.03 vs. 1.00 ± 0.04; 0.27 ± 0.03 vs. 0.81 ± 0.03; 0.29 ± 0.03 vs. 0.68 ± 0.02; 0.32 ± 0.03 vs.
0.59 ± 0.08 and 0.31 ± 0.04 vs. 0.61 ± 0.03 g/5min, respectively. Heart performance was directly related to pH value
(7.38 ± 0.06, 7.33 ± 0.03, 7.14 ± 0.04, 7.08 ± 0.04, 7.25 ± 0.03), the change in the rate pressure product being
21,702 ± 1969 vs. 21,291 ± 2,552; 22,098 ± 2,115 vs. 14,114 ± 3,386; 20,897 ± 2,083 vs. 10,671 ± 1,948; 21,822 ±
2,470 vs. 10,047 ± 2,320 and 20,955 ± 2,296 vs. 15,951 ± 2,755 mmHg × bpm, respectively.
Conclusions: It appears important to maintain the pH value within a physiological range to maintain optimal
myocardial contractility. Using colloids prepared in calcium-containing, balanced solutions for volume replacement
therapy may attenuate the breakdown of vascular barrier competence in the critically ill.
Introduction
For over 100 years vascular barrier competence was gener-
ally acknowledged to be sufficiently explained by the his-
torical principle of Ernest Starling [1]. This stipulated an
inwardly directed oncotic gradient between an interstitial
space presumably low in protein and the protein rich
plasma with percentage albumin at concentrations of
around 4 g% as main constituent. This gradient was con-
sidered to keep the compartments in balance, despite an
intravascular hydrostatic pressure, which forces fluids and
solutes outwards. The therapeutical target to prevent
interstitial oedema whilst maintaining cardiac preload in
the face of an unaffected endothelial cell line would have
been, according to this model, to merely maintain the
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oncotic plasma pressure. The practical answer was the
intravenous infusion of isooncotic colloids prepared in iso-
tonic saline, irrespective of their binding properties for
electrolytes and membrane coatings.
The last decade, however, has brought increasing evi-
dence that things might not be that easy. Various experi-
mental models showed that the interstitial oncotic
pressure in most organs is far from zero and, surprisingly,
does not relevantly influence transvascular filtration
behaviour [2]. This brought attention to the endothelial
glycocalyx, a negatively charged layer of proteoglycans
and glycosaminoglycans, now identified as an important
part of vascular barrier competence [3]. Due to its special
biophysical and biochemical properties, the glycocalyx
binds plasma constituents, forming the endothelial sur-
face layer with a functional thickness of more than 1 µm
[4]. It is only the oncotic gradient across this layer, that
is, between the protein-loaded glycocalyx and a small
space low in protein directly beneath, but completely at
the luminal side of the anatomical vessel wall, that helps
to limit hydrostatically driven outflow of plasma constitu-
ents in high-pressure segments of the circulation [2]. In
addition, the endothelial surface layer plays an important
role for shear stress transduction to the endothelial cells
and also for generating an anti-inflammatory, anti-
thrombotic and anti-adhesive vascular surface by har-
bouring adhesion molecules [5]. The fragile glycocalyx,
however, can be degraded in various pathophysiological
situations such as ischaemia/reperfusion, sepsis, hyper-
glycaemia, trauma or diabetes [6,7].
The integrity of the endothelial surface layer, which
seems to be strongly related to oedema formation and car-
diac performance [6], is strongly dependent on sufficient
concentrations of suitable plasma constituents [8]. More-
over, the binding properties of both glycocalyx and plasma
proteins should depend on plasma pH. Thus, acid-base
chemistry should be considered when clinicians assess
whether the composition of infusion preparations is ade-
quate. Furthermore, some constituents of these prepara-
tions might disrupt the competence of the endothelial
surface layer.
The present study investigated the influence of commer-
cially available crystalloidal and colloidal infusion prepara-
tions on coronary vascular integrity, interstitial oedema
and cardiac performance of isolated guinea-pig hearts. It
extends the insight into what actually happens to microcir-
culation when diluting natural plasma constituents with
artificial substitutes beyond a critical border. Therefore,
these data might already help us today to rationally select
a substitution solution for a critically ill patient, even in
the absence of outcome-based evidence. Beyond that, such
basic data may help to sharpen the focus of future devel-
opments in the field.
Materials and methods
The investigation conformed to the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85-23,
revised 1996) and was approved by - and licensure of the
investigator obtained from - the Government of Upper
Bavaria (Regierung von Oberbayern file No. 209.1/211-
2531.3-3/99).
Hearts were prepared in a non-working Langendorff
mode comparing basal conditions to intracoronary infusion
of different artificial solutions (details see below). The
unblinded study was arranged in three steps. Protocol 1
(Figure 1) assessed transvascular filtration immediately
before and during infusion of the respective test solution,
as well as interstitial water content at the end of protocol.
Also, quantitative and qualitative glycocalyx shedding was
determined. According to protocol 2 (Figure 1), human
polymorphonuclear neutrophilic granulocytes (PMN) were
infused intracoronarily and their adhesion rate was
assessed. Protocol 3 (Figure 1) compared changes of heart
performance and ionic and pH compositions when infusing
the different solutions. The normal ranges for electrolytes,
bicarbonate, phosphate and lactate in human plasma, in
comparison to the composition of the tested crystalloidal
and colloidal solutions, are presented in Table 1.
Heart preparation and perfusion
Basal preparations (protocols 1 and 2) (Figure 1)
Guinea pigs (male; weight 300 to 400 g) were stunned by
neck dislocation, and immediately after opening of the
thorax had their hearts arrested with ice-cold isotonic sal-
ine. The aorta was cannulated and the coronary arteries
were reperfused in situ at a constant flow rate of 6 ml/min-
ute (mean 37 ± SD 0.5°C, pH 7.40 ± 0.05). The perfusate
was administered by a peristaltic pump (Type: MS-1
REGLO/8-160; Ismatec™ SA Laboratoriumstechnik, Glatt-
brugg-Zürich, Switzerland), the perfusion pressure being
continuously recorded with a pressure transducer (FMI
GmbH, Engelsbach, Germany). An initial perfusion pres-
sure above 80 cm H2O predicted heart failure and led to
exclusion. Hearts were removed from the thorax and pre-
paration was finalised by ligating the caval and azygos veins
and inserting a cannula into the pulmonary artery [9,10].
Additional preparations (protocol 3) (Figure 1)
A thin, saline-filled latex balloon (Hugo Sachs Electronic
KG, March-Hugstetten, Germany) was inserted into the
left ventricle and attached via a metal cannula to a pres-
sure transducer (Isotec, Hugo Sachs Electronic KG)
enabling measurement of isovolumetric systolic left ventri-
cular pressure (LVP) development.
The initial intracoronary perfusion was carried out using
a modified Krebs-Henseleit buffer (KHB, composition:
116mM NaCl, 23 mM NaHCO3, 3.6 mM KCl, 1.16 mM
Zausig et al. Critical Care 2013, 17:R203
http://ccforum.com/content/17/5/R203
Page 2 of 10
Figure 1 Experimental protocols. Protocol 1: transudate formation (TF). Sample generation for assessing transudate formation and glycocalyx
shedding in control (TF-Control) and study groups (TF-NaCl, TF-Ri-Ac, TF-6% HES, TF-10% HES, and TF-Gel). The same hearts were used to determine
interstitial water content after the protocol, and in two additional cases in each group, for electron microscopy evaluation. Protocol 2:
polymorphonuclear neutrophils (PMN). The intracoronary adhesion rates of PMN were determined in control (PMN-Control) and study groups (PMN-
NaCl, PMN-Ri-Ac, PMN-6% HES, PMN-10% HES, and PMN-Gel) at the time indicated. Application and evaluation followed the detailed description given
within the running text. Protocol 3: heart performance (HP). The determination of heart performance occurred in control (HP-Control) and study
groups (HP-NaCl, HP-Ri-Ac, HP-6% HES, HP-10% HES, and HP-Gel) at the times indicated. For details, see Materials and methods.
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KH2PO4, 1.25 mM CaCl2, 0.58 mM MgSO4, 5.4 mM glu-
cose, 0.3 mM pyruvate, and 2.8 U/l insulin, gassed with
94.5% O2 and 5.5% CO2) augmented with 1 g% human
albumin from the onset of preparation. Electrolytes, pH
and oxygen tension (Gem Premier 4000, Il GmbH, Kirch-
heim, Germany) and osmolality (Advanced Osmometer
Model 2000, Advanced Instruments, Norwood, MA, USA)
were measured.
Experimental protocols
All hearts were randomly assigned to the respective
groups before starting the preparation.
Protocol 1 (Figure 1): transudate formation, glycocalyx
shedding and interstitial water content (TF)
Transudate formation
Transudate filtered from the coronary system was col-
lected on the epicardial surface in timed aliquots and
quantified while the coronary venous effluent was col-
lected from the pulmonary artery. Following preparation
and the first equilibration phase in a dry warming cham-
ber, the basal measurement of transudate formation was
performed between minutes 25 and 30. In the control
group (TF-Control, n = 6, protocol 1A) the perfusion
continued for another 15 minutes before a second collec-
tion was carried out (minutes 45 to 50). In the study
groups (TF-NaCl, TF-Ri-Ac, TF-6% HES, TF-10% HES
and TF-Gel, n = 6 each, protocol 1B), the perfusion was
switched after 15 minutes to a 1:1 mixture of buffer and
the respective test solution following the basal measure-
ment of transudate formation. The final determination
was performed between minutes 30 and 45 following a
second equilibration interval.
Glycocalyx shedding
Samples of coronary effluent were obtained from the
same hearts after the first equilibration phase and again
at the end of the second equilibration phase, each time
for 3 minutes, and were stored at -20°C. The concentra-
tion of syndecan-1 (CD 138), a main component of the
glycocalyx, was determined using an enzyme-linked
immunosorbent assay (Diaclone Research, Besancon,
France) as described before [11].
Tissue water content
At the end of the protocol, oedema formation was
assessed in each heart by measuring ventricular wet weight
(at once) and dry weight (after 24 h at 60°C). With intersti-
tial oedema formation the quotient - wet weight × dry
weight-1 - increases in vivo from a mean value of 4.76 [8].
Electron microscopy
Two additional hearts per group were treated as described
in protocol 1 for the TF-Control, TF-NaCl, TF-Ri-Ac, TF-
6% HES, TF-10% HES and TF-Gel groups, but were pre-
pared for electron microscopy (EM) as described pre-
viously [4] to qualitatively screen for morphological
correlates of infusion-related glycocalyx shedding.
Protocol 2 (Figure 1): adhesion of polymorphonuclear
neutrophils
Following preparation and the first equilibration phase the
Langendorff-perfusion continued for another 15 minutes
in the control group (PMN-Control, n = 6, protocol 2A)
before application of PMN. In the study groups (PMN-
NaCl, PMN-Ri-Ac, PMN-6% HES, PMN-10% HES and
PMN-Gel, n = 6 each, protocol 2B), the perfusion mode
switched to a 1:1 mixture of buffer and the respective test
solution after the first equilibration interval. A second
Table 1 Normal ranges of electrolyte, bicarbonate, phosphate and lactate in comparison to the composition of the
studied solutions
Plasma NaCl Ri-Ac 6% HES 10% HES Gel Unit of measurement
Kations
Sodium 137 to 147 154 130 130 130 144 mmol/l
Potassium 3.5 to 5.5 NA .5.4 .5.5 .5.5 5 mmol/l
Magnesium 0.8 to1.0 NA 1 1 1 .1.5 mmol/l
Calcium 2.2 to 2.6 NA 0.9 1 1 .2.5 mmol/l
Anions
Chloride 95 to 110 154 112 112.5 112.5 103 mmol/l
Bicarbonate 23 to 25 NA NA NA NA NA mmol/l
Phosphate 0.8 to 1.6 NA NA NA NA NA mmol/l
Acetate NA NA 27 27 27 27 mmol/l
Lactate 0.0 to 1.0 NA NA NA NA NA mmol/l
Colloids
HES NA NA NA 6 10 NA g%
Gelatine NA NA NA NA NA 4 g%
Theoretical osmolality 280 to 300 308 276 277 277 283 mosmol/kg H2O
NaCl, isotonic saline; Ri-Ac, ringer’s acetate; 6% and 10% HES: 6% and 10% hydroxyethyl starch in Ringer’s acetate. NA (not applicable).
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interval between minutes 30 and 45 preceded the assess-
ment of PMN adhesion under the respective study
conditions.
PMN of guinea pigs and humans show a quantitatively
similar degree of adhesion in our model [12]. Therefore,
the latter were used to substantially reduce the total
number of animals needed. Preparation, intracoronary
application and counting of non-adherent human PMN,
as well as calculation of their adhesion rate were carried
out as described previously [12]. Under basal conditions
intracoronary retention has been shown to be 21.6 ±
2.1% [12]. Experimental shedding of the glycocalyx by
intracoronary application of heparinase almost doubled
this adhesion rate to 37.3 ± 2.0% [4,13].
Protocol 3: heart performance (HP) (Figure 1)
For assessment of ventricular pressure development, bal-
loon volume was adjusted to an initial diastolic LVP of 0
mmHg during the control period. Thus, any increase in
diastolic LVP reflected an increase in left ventricular
wall stiffness or diastolic contracture. The rate pressure
product (RPP) was calculated as follows [14]:
RPP =
(
Left ventricular systolic pressure − Left ventricular diastolic pressure)×HR
Following preparation and equilibration phase I, base-
line values of HR, LVP and RPP were obtained. After
that, basal perfusion was continued (HP-Control, n = 6,
protocol 3A) or switched to the 1:1 mixture of buffer and
the respective test solution (HP-NaCl, HP-Ri-Ac, HP-6%
HES, HP-10% HES and HP-Gel, n = 6 each, protocol 3B).
HP was re-assessed following equilibration phase II.
Statistical analysis
The measured data are presented as mean ± SD, with n
indicating the number of experiments.
To calculate the number of hearts needed, we per-
formed a power calculation with G*Power 3.1 according
to Faul et al. [15]. With n = 6, alpha-level of 0.05 and an
assumed effect size
d >1, we expected a power level of 95% for the pairwise
t-test with matched pairs. This number would also fit
analyses of variance (ANOVA) with six groups and com-
parable values. The data for the effect size calculation
being more than 1SD were based on previous studies [8].
Comparisons were made using the Student t-test for
paired samples. For multiple comparisons, ANOVA was
performed with the Bonferroni correction. In the case of
unequal variances (group TF-Control and TF-NaCl),
identified by the Levene test for homogeneity of var-
iances, Dunnett’s T3-test was performed. A P-value less
than 0.05 was considered significant. The statistical soft-
ware used to conduct the analyses was SPSS 16 (SPSS
Inc., Chicago, IL, USA).
Results
Electron microscopy of exemplary hearts from the con-
trol and the 6% HES group showed a tight glycocalyx at
the endothelial surface at the end of perfusion protocols
(Figure 2). Because no morphological differences were
evident, tissue of hearts from other groups was not
further investigated at this stage.
Transudate formation and parameters related to HP
showed no significant intergroup differences under basal
conditions or between basal and second measurements in
the control groups, respectively. However, a significant
increase in transudate formation versus control conditions
was observed in all study groups upon dilution of the
modified, albumin-augmented KHB by artificial solutions
(Figure 3). Vascular leakage was highest in the colloid-free
groups TF-NaCl and TF-Ri-Ac, but significantly attenu-
ated versus that in colloid groups TF-6% HES, TF-10%
HES and TF-Gel. A complementary picture was found for
the tissue water content, the wet-to-dry weight ratio for
groups TF-NaCl, TF-Ri-Ac, TF-6% HES, TF-10% HES and
TF-Gel (7.29 ± 0.03, 7.16 ± 0.36, 7.00 ± 0.21, 6.83 ± 0.09
and 6.45 ± 0.21, respectively) being significantly increased
versus TF-Control (6.01 ± 0.03; n = 6 for each group;
TF-Control versus TF-NaCl, TF-Ri-Ac, TF-6% HES and
TF-10% HES: P <0.05; TF-10% HES versus TF-Control
and TF-NaCl: P <0.05; TF-Gel versus TF-Control,
TF-NaCl and TF-6% HES: P <0.05; TF-NaCl versus
TF-Control, TF-10% HES and TF-Gel: P <0.05; ANOVA:
df = 5; F = 25.380; P = 0.000; pairwise post hoc testing
performed with Dunnett’s T3-test).
PMN adhesion rates of groups PMN-Control, PMN-
NaCl, PMN-Ri-Ac, PMN-6% HES, PMN-10% HES and
PMN-Gel were 20.3 ± 0.6, 21.5 ± 0.5, 20.5 ± 1.0, 21.7 ±
1.2, 21.9 ± 1.1 and 20.6 ± 0.8%, respectively (n = 6 for
each group). Though adhesion of PMN during infusion
of 10% hydroxyethyl starch was significantly elevated
versus control conditions (ANOVA: df = 5; F = 3.777;
P = 0.009; pairwise post hoc test with Bonferroni correc-
tion: PNM-10% HES versus PNM-Control: P = 0.04; all
others not significant), this effect was minimal. Shedding
of syndecan-1 did not significantly differ among any of the
investigated groups (not shown).
Substituting one half of the KHB by 6% HES (HP-6%
HES), 10% HES (HP-10% HES) and HP-Ri-Ac decreased
heart rate significantly compared with the respective
basal value (174 ± 18 versus 221 ± 14, 176 ± 22 versus
216 ± 19 and 198 ± 25 versus 222 ± 17 bpm), whereas no
significant change was observed in group HP-Gel (222 ±
32 versus 217 ± 21 bpm). HP-NaCl, by contrast, showed
a significant increase compared to the basal value (249 ±
14 versus 220 ± 21 bpm; n = 6 for each group; respective
control versus study measurement of HP-NaCl, HP-Ri-
Ac, HP-6% HES and HP-10% HES: P <0.05; HP-NaCl
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and HP-Gel versus HP-6% HES and HP-10% HES:
P <0.05; ANOVA: df = 5; F = 19.458; P <0.001; pairwise
post hoc testing performed with the Bonferroni correction).
LVP remained constant in control hearts (94 ± 12 versus
96 ± 11 mmHg), but decreased significantly during perfu-
sion in all study groups versus the respective basal value
(71 ± 13 versus 100 ± 9; 61 ± 7 versus 95 ± 11; 57 ± 11
versus 101 ± 10 and 72 ± 12 versus 97 ± 6 mmHg for
groups HP-Ri-Ac, HP-6% HES, HP-10% HES and HP-Gel,
respectively), except for HP-NaCl (86 ± 14 versus 99 ±
8 mmHg; n = 6 for each group; control versus HP-Ri-Ac,
HP-6% HES, HP-10% HES and HP-Gel: P <0.05; HP-NaCl
versus HP-10% HES: P <0.05; ANOVA: df = 5; F = 11.364;
P <0.001; pairwise post hoc testing performed with the
Bonferroni correction).
These alterations resulted in significant decreases in the
RPP compared to basal values (14,114 ± 3,386 versus
22,098 ± 2,115; 10,671 ± 1,948 versus 20,897 ± 2,083;
Vascular lumen Vascular lumen
Endothelial cellEndothelial cell 300 nm300 nm
Endothelial glycocalyx
Endothelial glycocalyx
Figure 2 Endothelial glycocalyx. Exemplary electron microscopy picture of an intact endothelial glycocalyx after perfusion under control
conditions (TF-Control, left panel) and after intracoronary infusion of 6% hydroxyethyl starch (TF-6% HES, right panel).
Figure 3 Vascular integrity. Transudate formation (all data expressed as mean ± SD; n = 6 for each group). Filled bars, basal measurement;
open bars, second or study measurement. There were no significant differences among the basal measurements of all groups (analysis of
variance (ANOVA): df = 5; F = 0.444; P = 0.814). *P <0.05 basal measurement versus study measurement (Student’s paired t-test); +P <0.05 versus
all other basal and second/study measurements; #P <0.05 versus all other basal and second/study measurements except study measurement
of TF-10% HES; §P <0.05 versus all other basal and second/study measurements except TF-6% HES and TF-Gel (ANOVA: df = 5; F = 172,644;
P = 0.000; pairwise post hoc test performed with Dunnett´s T3-test).
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10,047 ± 2,320 versus 21,822 ± 2,470 and 15,951 ± 2,755
versus 20,955 ± 2,296 mmHg × bpm) (Figure 4).
The perfusate pH value was significantly reduced versus
the modified KHB during perfusion with Ri-Ac (7.33 ±
0.03), 6% HES (7.14 ± 0.04), 10% HES (7.08 ± 0.04) and
Gel (7.25 ± 0.03), all P <0.05, whereas NaCl did not cause
a significant change (7.38 ± 0.06; P >0.05). During infusion
of artificial solutions, electrolyte concentrations in the aor-
tic inflow showed drug-dependent deviations. There was a
reduction of sodium and calcium in all study groups with
the exception of the NaCl group (Table 2). Potassium was
only significantly decreased versus the basal perfusate in
the NaCl group, whereas all other solutions led to a slight,
albeit significant increase (P <0.05). Osmolality was not
different among the groups (Table 2).
Discussion
Our study evaluated the impact of intracoronary infu-
sion of commercially available crystalloidal and colloidal
infusion preparations (test solutions, see Table 1) on
coronary vascular integrity, HP, PMN adhesion and
oedema formation of isolated guinea-pig hearts, with spe-
cial focus on the endothelial glycocalyx. According to
recent knowledge we augmented the basal Krebs-Henseleit
perfusate with 1 g% human albumin to generate a suffi-
ciently functional endothelial surface layer. As in vivo, this
results from combining an intact endothelial glycocalyx
with plasma proteins. Previous work [4,8] and preliminary
experiments suggested that it might be difficult to generate
marked disturbances of the endothelial surface layer when
starting with physiological albumin concentrations around
4g%, because coronary washout requires too long [8].
Accordingly, by augmenting the buffer with merely 1g%
human albumin we simulated conditions of a hypo-albu-
minaemic patient. Infusion of artificial solutions was simu-
lated by replacing one half of the initial buffer, leading to a
further reduction of the intracoronary albumin content
towards 0.5g%. This protocol disclosed some marked
effects.
Actual shedding of the endothelial glycocalyx was
obviously not initiated by any solution or condition simu-
lated, as demonstrated by no increase in the glycocalyx
constituent syndecan-1 in coronary effluent, no morpho-
logical hint on the basis of electron microscopic exami-
nation, and no relevant increase in leukocyte adhesion.
However there were some considerable functional defects
of vascular competence. In particular, we observed an
increase in transudate, the equivalent of lymph flow in
the isolated heart model and a direct measure of vascular
fluid leak. This was noted especially when using colloid-
free infusion solutions, these obviously diluting the col-
loid content of the net perfusate below a critical level.
Presumably, this pathological microvascular disturbance
is reversible, because no overt damage to the glycocalyx
was detected.
Interestingly, infusion of the non-balanced sodium chlor-
ide had, despite a physiological pH-value of the mixed per-
fusate, a significantly worse effect on vascular leak than
infusion of the balanced Ringer’s acetate solution, which
led to a slight metabolic acidosis of the perfusate in our
model. These effects on pH value, however, are totally con-
trary to those seen under clinical conditions, where the
Figure 4 Haemodynamic performance. Rate-pressure product (RPP, all data expressed as mean ± SD; n = 6 for each group). Filled bars, basal
measurement; open bars, second or study measurement. *P <0.05 versus Control; #P <0.05 versus HP-NaCl (analysis of variance: df = 5;
F = 29.361; P <0.001; pairwise post hoc testing performed with the Bonferroni correction).
Zausig et al. Critical Care 2013, 17:R203
http://ccforum.com/content/17/5/R203
Page 7 of 10
infusion of sodium chloride is associated with severe hyper-
chloraemic acidosis, which does not occur with balanced
solutions [16]. The reason is that after intravenous infusion
into the human circulation, the anion acetate is rapidly
metabolised into bicarbonate, preventing acidosis. The iso-
lated heart is obviously unable to metabolise acetate rapidly
enough to prevent an artificial acidosis. Therefore, the anti-
acid effect of balanced solutions might be underestimated
in this in-vitro study. Isotonic saline, by contrast, is inert in
terms of acid-base chemistry in our model, but causes
severe hyperchloraemic acidosis in vivo [17]. Accordingly,
it would seem there is an additional beneficial impact of
balanced solutions on coronary vascular permeability,
beyond pure osmotic and pH phenomena, most likely
related to the ionic composition. The higher concentra-
tions of potassium and free calcium ions would be the
most likely ones. In particular, calcium should play an
important role in this context, an ion that is not present in
sodium chloride solution but in all other solutions tested
here.
Both 6 and 10% hydroxyethyl starch and 4% gelatine
are also based on balanced crystalloid and additionally,
contain an artificial colloid. Although previous work sug-
gests that hydroxyethyl starch should be inferior to
human albumin in terms of interaction with the glycoca-
lyx to form an endothelial surface layer, the present study
applied the artificial colloids in combination with human
albumin, thus imitating the scenario of clinical practice.
As was to be expected, these preparations were able to
maintain vascular barrier function much better than crys-
talloids [4]. Hypothetically, the mainly negative charges
of gelatine, being a protein, could imitate the properties
of natural plasma proteins much better than starch, a
carbohydrate molecule derived from plants. Indeed,
tissue oedema proved to be lower in hearts perfused
with gelatine solution, suggestive of a tighter endothelial
surface layer.
The in-vitro observations of HP display a direct rela-
tionship to the pH value of the coronary inflow: the more
acidosis, the more decrease in LVP and HR. A tight
control of acidosis might thus preserve myocardial func-
tioning, which confirms the results of previous studies
[17]. It has been shown that acidosis indirectly influences
excitation-contraction coupling by decreasing the deliv-
ery of calcium to the myofilaments (for example, by inhi-
bition of calcium current at the calcium channel or
calcium release of the sacroplasmic reticulum), leading to
depressed myocardial performance [18,19].
Additionally, reduction of the calcium concentration in
the perfusate due to the addition of artificial solutions
(Table 2) might have also affected left ventricular func-
tion. In isolated heart models, calcium - one of the key
determinants of contractile function - shows a direct
relationship with left ventricular developed pressure. It is
of note that the HP-NaCl group was the only one with an
increase in heart rate, possibly due to the reduced potas-
sium concentration. This increase might have offset the
effects of reduced pH and calcium concentration on left
ventricular performance.
It is difficult to rule out any direct or indirect effects
of the tested artificial colloids on the rate-pressure pro-
duct. For example, there is a study showing that artifi-
cial colloids as additive to cardioplegic solution do have
an influence on myocardial oedema development and
preserve cardiac function [20]. However, these particular
results pertain to ischaemia-reperfusion conditions and
there was a different composition of the perfusion solu-
tion. Other data suggest that artificial colloids affect
endothelial function by reducing endothelium-depen-
dent relaxation and the endothelium-derived hyperpo-
larising factor [21]. This might interfere with coronary
flow regulation, thereby indirectly influencing left ventri-
cular function [22]. However, as we used constant flow
perfusion to provide an additional element of constancy
in our study, autoregulatory coronary flow mechanisms
would be overridden and any such colloidal endothelial
effects neutralised. As opposed to such vague possible
actions of the different colloids, the changes in pH of the
final perfusate mixtures are closely aligned to the
observed functional changes on rate-pressure product (cf.
Table 2 Values measured within effective perfusate during study phase without (HP-Control) and with (HP-NaCl,
HP-Ri-Ac, HP-6% HES, HP-10% HES and HP-Gel) infusion of respective preparation according to the study protocol
HP-Control HP-NaCl HP-Ri-Ac HP-6% HES HP-10% HES HP-Gel Unit of measurement
Sodium 139 ± 1 148 ± 2*# 133 ± 2* 134 ± 4* 136 ± 2* 136 ± 2* mmol/l
Potassium .3.78 ± 0.04 .1.77 ± .0.05*# .4.41 ± .0.09* .4.46 ± .0.12* .4.49 ± .0.09* .4.21 ± .0.09* mmol/l
Calcium .1.86 ± 0.05 .0.97 ± .0.04*# .1.33 ± .0.02* .1.39 ± .0.05* .1.44 ± .0.04* .1.49 ± .0.11* mmol/l
Osmolarity 269 ± 26 266 ± 34 256 ± 24 274 ± 16 276 ± 25 276 ± 5 mosmol/l
pH .7.43 ± 0.04 .7.38 ± .0.06 .7.33 ± .0.03* .7.14 ± .0.04* .7.08 ± .0.04* .7.25 ± .0.03*
Electrolyte concentrations, osmolarity and pH in perfusate, assessed in the delivering lines of the HP groups under basal conditions (HP-Control) and after having
switched to infusion mode using the respective study solutions (HP-NaCl, HP-Ri-Ac, HP-6% HES, HP-10% HES, and HP-Gel). All data expressed in mean ± SD; n =
6 for each group; *P <0.001 versus HP-Control; #P <0.001 versus HP-Ri-Ac, HP-6% HES, HP-10% HES, and HP-Gel. HP, heart performance; NaCl, isotonic saline; Ri-
Ac, ringer’s acetate; 6% and 10% HES: 6% and 10% hydroxyethyl starch in Ringer’s acetate.
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Table 2 and Figure 4). There was no such association for
the level of potassium.
An important limitation of our results is the use of red
blood cell-free perfusates. This is associated with a low
viscosity and a low CaO2 (PaO2/oxygen content) and leads
to a higher coronary blood flow than in vivo, possibly asso-
ciated with an increase of shear stress, and consequently an
endothelial release of vasoactive substances [23]. Admix-
ture of colloids will also influence viscosity and shear stress
versus crystalloid buffers. To alleviate such influences, our
perfusion was flow controlled, which additionally elimi-
nated possible effects on flow leading to Gregg’s phenom-
enon [24]. However, because red blood cells influence
metabolic and acid-base balances, somewhat different
results for the haemodynamic parameters cannot be ruled
out in the event of admixture to whole blood [25].
Conclusions
The presented study investigated the impact of intracor-
onary perfusion of crystalloidal and colloidal infusion
preparations as used in the clinical setting in an isolated
guinea-pig heart model. In no case was there evidence for
rapid destruction of the endothelial glycocalyx. Neverthe-
less, the tested solutions produced a notable breakdown of
vascular competence, which was most impressive when
using isotonic saline and significantly attenuated when
using colloidal infusions. Infringement of heart perfor-
mance showed a correlation with a decreasing pH. There-
fore, maintaining the pH value within a physiological
range is important to preserve myocardial function.
Prevention of oedema requires the use of colloids prepared
in calcium-containing, balanced solutions for volume
replacement therapy.
Key points
• Isotonic saline in colloidal infusions shows notable
breakdown of vascular competence.
• It appears important to maintain the pH value within
a physiological range to maintain optimal myocardial
contractility.
• Oedema formation may be limited by using colloids
prepared in calcium-containing, balanced solutions for
volume replacement therapy, instead of crystalloids.
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